Literature DB >> 21414494

Lyme disease: Part II. Management and prevention.

Chinmoy Bhate1, Robert A Schwartz.   

Abstract

Lyme disease (LD) is most often diagnosed clinically, and the differential diagnosis of erythema migrans may be challenging. Recent advances have raised questions about the efficacy of traditional diagnostic modalities, but may soon facilitate consistent identification of patients with Lyme borreliosis. Therapeutic recommendations vary with the stage of disease, and treatment usually leads to complete resolution. The management of patients with "chronic Lyme disease" is controversial. A number of preventative measures have been evaluated; those involving the avoidance of tick bites with protective clothing and insect repellents remain the simplest and most effective.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414494     DOI: 10.1016/j.jaad.2010.03.047

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Provider knowledge, attitudes, and practices regarding Lyme disease in Arkansas.

Authors:  Dana Hill; Talmage Holmes
Journal:  J Community Health       Date:  2015-04

2.  [Diagnosis and treatment of Lyme arthritis. Recommendations of the Pharmacotherapy Commission of the Deutsche Gesellschaft für Rheumatologie (German Society for Rheumatology)].

Authors:  M Gaubitz; F Dressler; H I Huppertz; A Krause
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

3.  Biomonitoring and evaluation of permethrin uptake in forestry workers using permethrin-treated tick-proof pants.

Authors:  Bernd Rossbach; Peter Kegel; Heike Süß; Stephan Letzel
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-05-13       Impact factor: 5.563

4.  DNA persistence after treatment of Lyme borreliosis.

Authors:  D Pícha; L Moravcová; D Vaňousová; J Hercogová; Z Blechová
Journal:  Folia Microbiol (Praha)       Date:  2013-08-09       Impact factor: 2.099

5.  Immunization with a Borrelia burgdorferi BB0172-derived peptide protects mice against lyme disease.

Authors:  Christina M Small; Dharani K Ajithdoss; Aline Rodrigues Hoffmann; Waithaka Mwangi; Maria D Esteve-Gassent
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

6.  Determination of Seroprevalence of Borrelia burgdorferi IgG in Adult Population Living in Trabzon.

Authors:  Merve Cora; Neşe Kaklıkkaya; Murat Topbaş; Gamze Çan; Asuman Yavuzyılmaz; İlknur Tosun; Faruk Aydın
Journal:  Balkan Med J       Date:  2017-01-05       Impact factor: 2.021

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.